{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:48:22Z","timestamp":1787014102324,"version":"build-2736575974"},"reference-count":62,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":608,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1111\/dth.12003","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T12:38:50Z","timestamp":1391690330000},"page":"1-11","source":"Crossref","is-referenced-by-count":5,"title":["The clinical significance of drug interactions between dermatological and psychoactive medications"],"prefix":"10.1155","volume":"27","author":[{"given":"John W.","family":"Frew","sequence":"first","affiliation":[{"name":"Royal Prince Alfred Hospital; Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"key":"10.1111\/dth.12003-BIB0001|dth12003-cit-0001","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1529-8019.2008.00172.x","article-title":"Psychopharmacology in dermatology","volume":"21","author":"Lee","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1111\/dth.12003-BIB0002|dth12003-cit-0002","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2230.2009.03497.x","article-title":"Psychiatric treatments in dermatology: an update","volume":"35","author":"Sambhi","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/dth.12003-BIB0003|dth12003-cit-0003","first-page":"35","article-title":"Psychiatric issues in dermatology, part 1: atopic dermatitis and psoriasis","volume":"15","author":"Levenson","year":"2008","journal-title":"Prim Psychiatry"},{"key":"10.1111\/dth.12003-BIB0004|dth12003-cit-0004","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1468-3083.2001.00278.x","article-title":"The use of antidepressant drugs in dermatology","volume":"15","author":"Gupta","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/dth.12003-BIB0005|dth12003-cit-0005","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Brunton","year":"2011"},{"key":"10.1111\/dth.12003-BIB0006|dth12003-cit-0006","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2230.2008.02904.x","article-title":"Drug interactions in dermatological practice","volume":"33","author":"Tey","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/dth.12003-BIB0007|dth12003-cit-0007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00520-006-0127-5","article-title":"The pharmacological importance of CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions","volume":"15","author":"Haddad","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1111\/dth.12003-BIB0008|dth12003-cit-0008","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/03602532.2010.484462","article-title":"Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids","volume":"42","author":"Dvorak","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1111\/dth.12003-BIB0009|dth12003-cit-0009","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1345\/aph.1K628","article-title":"Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?","volume":"42","author":"Lam","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1111\/dth.12003-BIB0010|dth12003-cit-0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/clpt.1989.42","article-title":"Impact of ketoconazole on the metabolism of prednisolone","volume":"45","author":"Zurcher","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/dth.12003-BIB0011|dth12003-cit-0011","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1034\/j.1399-3046.1999.00027.x","article-title":"Diltiazem retards the metabolism of oral prednisone with effects on T-cell markers","volume":"3","author":"Imani","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1111\/dth.12003-BIB0012|dth12003-cit-0012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002280050720","article-title":"The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone","volume":"56","author":"Varis","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/dth.12003-BIB0013|dth12003-cit-0013","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00002018-200022020-00004","article-title":"Corticosteroid-induced adverse psychiatric effects","volume":"22","author":"Patten","year":"2000","journal-title":"Drug Saf"},{"key":"10.1111\/dth.12003-BIB0014|dth12003-cit-0014","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0304-3940(03)00261-1","article-title":"Modulation of the human glucocorticoid receptor function by antidepressive compounds","volume":"342","author":"Okuyama-Tamura","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1111\/dth.12003-BIB0015|dth12003-cit-0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.mehy.2005.12.037","article-title":"Combined dexamethasone suppression\/corticotropin-releasing hormone stimulation test and antidepressants: different antidepressant may produce different effects","volume":"66","author":"Sher","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1111\/dth.12003-BIB0016|dth12003-cit-0016","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1345\/aph.1K316","article-title":"Lack of pharmacokinetic interaction between St. John's wort and prednisone","volume":"41","author":"Bell","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1111\/dth.12003-BIB0017|dth12003-cit-0017","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.nrl.0000340792.61037.40","article-title":"Antiepileptic drug interactions","volume":"14","author":"Saiz Diaz","year":"2008","journal-title":"Neurologist"},{"key":"10.1111\/dth.12003-BIB0018|dth12003-cit-0018","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1176\/ajp.155.11.1626","article-title":"Clarithromycin-induced mania","volume":"155","author":"Abouesh","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1111\/dth.12003-BIB0019|dth12003-cit-0019","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/070674379704200718","article-title":"Case of mania due to prednison-clarithromycin interaction","volume":"42","author":"Finkenbine","year":"1997","journal-title":"Can J Psychiatry"},{"key":"10.1111\/dth.12003-BIB0020|dth12003-cit-0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-0773.1998.tb01457.x","article-title":"The effect of dexamethasone on the pharmacokinetics of triazolam","volume":"83","author":"Villikka","year":"1998","journal-title":"Pharmacol Toxicol"},{"key":"10.1111\/dth.12003-BIB0021|dth12003-cit-0021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.159.2.255","article-title":"Clozapine, olanzapine, risperidone and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder","volume":"159","author":"Volavkva","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1111\/dth.12003-BIB0022|dth12003-cit-0022","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.clpt.6100116","article-title":"Pharmacokinetics of mirtazepine: enantioselective effects of the CYP2D6 ultra rapid metaboliser genotype and correlation with adverse effects","volume":"81","author":"Brockmoller","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/dth.12003-BIB0023|dth12003-cit-0023","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/070674370905400408","article-title":"An epidemiologic study of psychotropic medication and obesity-related chronic illnesses in older psychiatric patients","volume":"54","author":"Kisely","year":"2009","journal-title":"Can J Psychiatry"},{"key":"10.1111\/dth.12003-BIB0024|dth12003-cit-0024","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.det.2008.07.011","article-title":"Oral antibiotic drug interactions of clinical significance to dermatologists","volume":"27","author":"Del Rosso","year":"2009","journal-title":"Dermatol Clin"},{"key":"10.1111\/dth.12003-BIB0025|dth12003-cit-0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/dth.12003-BIB0026|dth12003-cit-0026","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2125.1997.t01-1-00619.x","article-title":"Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes","volume":"44","author":"Zhao","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/dth.12003-BIB0027|dth12003-cit-0027","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/00365540903140691","article-title":"Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient","volume":"41","author":"Gallien","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/dth.12003-BIB0028|dth12003-cit-0028","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00228-009-0631-x","article-title":"Tigecycline and cyclosporine interaction - an interesting case of biliary-excreted drug enhancing the oral bioavailability of cyclosporine","volume":"65","author":"Srinivas","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/dth.12003-BIB0029|dth12003-cit-0029","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1538-7836.2008.02844.x","article-title":"Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants","volume":"6","author":"Penning-van Beest","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/dth.12003-BIB0030|dth12003-cit-0030","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijantimicag.2009.04.011","article-title":"In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms","volume":"34","author":"Miceli","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/dth.12003-BIB0031|dth12003-cit-0031","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00002018-199513020-00005","article-title":"Macrolide antibacterials: drug interactions of clinical significance","volume":"13","author":"Rosensteil","year":"1995","journal-title":"Drug Saf"},{"key":"10.1111\/dth.12003-BIB0032|dth12003-cit-0032","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/RHU.0b013e3181bbbcd7","article-title":"Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis","volume":"15","author":"McKinnell","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/dth.12003-BIB0033|dth12003-cit-0033","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004714-198610000-00008","article-title":"A pharmacokinetic interaction between erythromycin and triazolam","volume":"6","author":"Phillips","year":"1986","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/dth.12003-BIB0034|dth12003-cit-0034","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1055\/s-0028-1082071","article-title":"Major increase in quetiapine steady-state plasma concentration following co-administration of clarithromycin: confirmation of the pharmacokinetic interaction potential of quetiapine","volume":"41","author":"Schulz-Du Bois","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1111\/dth.12003-BIB0035|dth12003-cit-0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00228-010-0820-7","article-title":"Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9","volume":"66","author":"Hellden","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/dth.12003-BIB0036|dth12003-cit-0036","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00003495-200059020-00003","article-title":"Important drug interactions in dermatology","volume":"59","author":"Roos","year":"2000","journal-title":"Drugs"},{"key":"10.1111\/dth.12003-BIB0037|dth12003-cit-0037","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archderm.1992.01680130095013","article-title":"Psychodermatology","volume":"128","author":"Koo","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1111\/dth.12003-BIB0038|dth12003-cit-0038","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000073989","article-title":"Psychopharmacology in dermatological practice: a review and update","volume":"4","author":"Lee","year":"2003","journal-title":"Dermatol Psychosom"},{"key":"10.1111\/dth.12003-BIB0039|dth12003-cit-0039","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0733-8635(03)00027-5","article-title":"The use of oral antifungal agents to treat onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1111\/dth.12003-BIB0040|dth12003-cit-0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00007691-199702000-00010","article-title":"Griseofulvin and fluvoxamine interactions with the metabolism of theophylline","volume":"19","author":"Rasmussen","year":"1997","journal-title":"Drug Monit"},{"key":"10.1111\/dth.12003-BIB0041|dth12003-cit-0041","first-page":"73","article-title":"Drug interaction between cyclosporine and two anti-microbial agents, josamycin and rifampicin, in organ-transplanted patients","volume":"16","author":"Capone","year":"1996","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1111\/dth.12003-BIB0042|dth12003-cit-0042","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clpt.2005.03.004","article-title":"Drug interaction between mycophenolate mofetil and rifampin: possible induction of uridine DiPhosphate-glucuronossyltransferase","volume":"78","author":"Kuypers","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/dth.12003-BIB0043|dth12003-cit-0043","first-page":"239","article-title":"Glucocorticoid-treated bullous pemphigoid interfered by rifampicin: a case report","volume":"38","author":"Chen","year":"2009","journal-title":"J Clin Dermatol"},{"key":"10.1111\/dth.12003-BIB0044|dth12003-cit-0044","first-page":"208","article-title":"Drug-drug interactions between voriconazole and rifampicin","volume":"144","author":"Rommers","year":"2009","journal-title":"Pharm Weekbl"},{"key":"10.1111\/dth.12003-BIB0045|dth12003-cit-0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00000441-199602000-00004","article-title":"Interaction of rifampin and nortryptiline","volume":"311","author":"Self","year":"1995","journal-title":"Am J Med Sci"},{"key":"10.1111\/dth.12003-BIB0046|dth12003-cit-0046","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3346\/jkms.2008.23.4.734","article-title":"Probable case of neuroleptic malignant syndrome following administration of antituberculotic drugs in a chlorpromazine-treated patient","volume":"23","author":"Shim","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1111\/dth.12003-BIB0047|dth12003-cit-0047","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1592\/phco.25.3.435.61591","article-title":"Exacerbation of panic disorder with rifampicin therapy in a patient receiving citalopram","volume":"25","author":"Kukoyl","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1111\/dth.12003-BIB0048|dth12003-cit-0048","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1067\/mjd.2001.114733","article-title":"Dapsone and sulfones in dermatology: overview and update","volume":"45","author":"Zhu","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12003-BIB0049|dth12003-cit-0049","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1111\/dth.12003-BIB0050|dth12003-cit-0050","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jac\/dkn330","article-title":"Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs","volume":"62","author":"Sousa","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/dth.12003-BIB0051|dth12003-cit-0051","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1610-0387.2010.07490.x","article-title":"Use of antimalarials in dermatology","volume":"8","author":"Falk","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/dth.12003-BIB0052|dth12003-cit-0052","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3797\/scipharm.1106-18","article-title":"Study on cytochrome P-450 dependent retinoic Acid metabolism and its inhibitors as potential agents for cancer therapy","volume":"79","author":"Ahmad","year":"2011","journal-title":"Sci Pharm"},{"key":"10.1111\/dth.12003-BIB0053|dth12003-cit-0053","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2230.2011.04034.x","article-title":"Pharmacokinetic interactions between alitretinoin and ketoconzole or simvastatin or ciclosporin A","volume":"36","author":"Schmitt-Hoffman","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/dth.12003-BIB0054|dth12003-cit-0054","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1331\/JAPhA.2010.09133","article-title":"Psuedotumor cerebri due to potentiation of all-trans retinoic acid by voriconazole","volume":"50","author":"Dixon","year":"2010","journal-title":"J Am Pharm Assoc (Wash DC)"},{"key":"10.1111\/dth.12003-BIB0055|dth12003-cit-0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00128071-200506010-00004","article-title":"Induced intracranial hypertension in dermatology","volume":"6","author":"Freidman","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/dth.12003-BIB0056|dth12003-cit-0056","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00002826-200309000-00007","article-title":"Drug induced pseudotumor cerebri","volume":"26","author":"Uddin","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/dth.12003-BIB0057|dth12003-cit-0057","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/10398560601147020","article-title":"Prolonged anticholenergic delirium following antihistamine overdose","volume":"15","author":"Scott","year":"2007","journal-title":"Australas Psychiatry"},{"key":"10.1111\/dth.12003-BIB0058|dth12003-cit-0058","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.clinthera.2008.08.011","article-title":"Drug interactions between chemotherapeutic regimens and antiepileptics","volume":"30","author":"Yap","year":"2008","journal-title":"Clin Ther"},{"key":"10.1111\/dth.12003-BIB0059|dth12003-cit-0059","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/leu.2009.6","article-title":"Antiepileptic drugs reduce efficacy of methotrexate chemotherapy by downregulation of reduced folate carrier transport activity","volume":"23","author":"Halwachs","year":"2009","journal-title":"Leukaemia"},{"key":"10.1111\/dth.12003-BIB0060|dth12003-cit-0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5414\/CN106886","article-title":"Cytochrome p450 polymorphisms and the response of lupus nephritis to cyclophosphamide therapy","volume":"75","author":"Winoto","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1111\/dth.12003-BIB0061|dth12003-cit-0061","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.psym.2010.12.007","article-title":"Two cases of serotonin syndrome with venlafaxine and calcineurin inhibitors","volume":"52","author":"Newey","year":"2011","journal-title":"Psychosomatics"},{"key":"10.1111\/dth.12003-BIB0062|dth12003-cit-0062","first-page":"3","article-title":"Pharmacogenomics of antipsychotic efficacy for schizophrenia","volume":"65","author":"Cacabelos","year":"2011","journal-title":"Jpn Soc Psychiatry Neurol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12003","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12003\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T13:00:46Z","timestamp":1671800446000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12003"}},"subtitle":["Dermatological and Psychoactive Medications"],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12003","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}